William P. Forbes

Companies

• HERON THERAPEUTICS, INC. /DE/EVP, Chief Development Officer Jun 12, 2023 to now¹
• Beyond Air, Inc.Board member Nov 15, 2019 to now²
• Trevi Therapeutics, Inc.Chief Development Officer Feb 3, 2021 to Jul 1, 2022³
• Salix PharmaceuticalsPresident Mar 11, 2015 to Apr 3, 2015⁴
• Salix PharmaceuticalsV.P. Research& Devel & CDO Jul 17, 2006 to Mar 9, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• HTHERON THERAPEUTICS, INC. /DE/ HRTX241,173 shares⁶$91.6K at $0.38Jul 31, 2026
• BABeyond Air, Inc. XAIR14,855 shares⁷$32.4K at $2.18Mar 31, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 31, 2026Shares withheld for tax 3,326 shares at $0.50 of HERON THERAPEUTICS, INC. /DE/⁶
• Jul 31, 2026Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/⁶
• Jul 30, 2026Shares withheld for tax 3,348 shares at $0.50 of HERON THERAPEUTICS, INC. /DE/⁶
• Jul 30, 2026Exercised options 11,769 shares of HERON THERAPEUTICS, INC. /DE/⁶
• Jul 19, 2026Shares withheld for tax 1,101 shares at $0.47 of HERON THERAPEUTICS, INC. /DE/⁸
• Jul 19, 2026Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/⁸
• Jun 6, 2026Exercised options 12,500 shares of HERON THERAPEUTICS, INC. /DE/⁹
• Apr 30, 2026Exercised options 11,770 shares of HERON THERAPEUTICS, INC. /DE/¹⁰
• Apr 30, 2026Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/¹⁰
• Apr 19, 2026Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/¹¹
• Jan 31, 2026Exercised options 11,695 shares of HERON THERAPEUTICS, INC. /DE/¹²
• Jan 19, 2026Exercised options 3,875 shares of HERON THERAPEUTICS, INC. /DE/¹³
• Oct 31, 2025Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/¹⁴
• Oct 19, 2025Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/¹⁵
• Jul 31, 2025Exercised options 11,695 shares of HERON THERAPEUTICS, INC. /DE/¹⁶
• Jul 19, 2025Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/¹⁷
• Jun 6, 2025Exercised options 12,500 shares of HERON THERAPEUTICS, INC. /DE/¹⁸
• Apr 30, 2025Exercised options 11,694 shares of HERON THERAPEUTICS, INC. /DE/¹⁹
• Apr 19, 2025Exercised options 3,875 shares of HERON THERAPEUTICS, INC. /DE/²⁰
• Jan 19, 2025Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/²¹
• Oct 19, 2024Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/²²
• Jul 19, 2024Exercised options 3,875 shares of HERON THERAPEUTICS, INC. /DE/²³
• Jun 6, 2024Exercised options 12,500 shares of HERON THERAPEUTICS, INC. /DE/²⁴
• Apr 19, 2024Exercised options 3,874 shares of HERON THERAPEUTICS, INC. /DE/²⁵
• Nov 17, 2023Bought 25,000 shares at $1.09 of HERON THERAPEUTICS, INC. /DE/²⁶